SCOUT Report – New data demonstrating significantly lower re-excision rates with the SCOUT



SCOUT Significantly Reduces Re-excision Rates

New data demonstrating significantly lower re-excision rates with the
radar localization system compared to wire localization (WL) was presented recently at the 12th Annual Academic Surgical Congress by Quyen Chu. MD, from
Louisiana State University (LSU) Health Sciences Center-Shreveport, LA.  LSU was an early adopter of SCOUT utilizing the technology since November 2015.  
The study evaluated 26 SCOUT cases, 17 of which were malignant, and an IRB-approved retrospective chart review of 116 WL patients for comparison.

The average re-excision rate for SCOUT was 11.8% compared with 37% for WL, translating to 68% reduction in re-excision rates with SCOUT. The average specimen weight was 55g for the SCOUT cohort versus 63g for WL cohort, with an average margin width of 3.0mm for SCOUT versus 2.7mm for WL.
As part of this study, investigators also assessed surgical trainees’ ability to perform the SCOUT radar localization procedure.  Residents were successfully able to localize the lesion in 25/26 cases (96%), demonstrating ease of use with the device.
Dr. Chu shares his perspectives on the radar localization system.   
What prompted you to adopt SCOUT?
I learned about SCOUT from our SAVI Brachy account manager and it just clicked with me right away.  We were using wire localization, a very old procedure, and it was time for a change.  We were not interested in radioactive seed localization due to the stringent regulatory requirements.  This was exactly what we needed.   
What do you believe are the key clinical benefits of SCOUT?  
The first key benefit is the reduction in re-excision rates and now we have the data to demonstrate it.  Secondly, I can perform a better oncoplastic procedure.  With a WL you are limited to following the path of the wire, with SCOUT I can use the guide to find the reflector signal and then plan my incision accordingly.  I have so much more control.   This leads to a much better cosmetic outcome for my patients.   

Quyen D. Chu, M.D., M.B.A., F.A.C.S. is a professor of surgery, vice-chair of academic affairs, chief of surgical oncology, and the Charles Knight, Sr. Endowed Professor of Surgery at Louisiana State University Health Sciences Center-Shreveport (LSUHSC-S), Shreveport, Louisiana. He was appointed by President Barack Obama in 2013 to be on the Vietnam Education Foundation (VEF) Board. Dr. Chu has published over 170 peer-reviewed papers/abstracts, 19 book chapters, spearheaded the effort to translate the WHO textbook, “Surgical Care at the District Hospital” into Vietnamese and co-edited a textbook title, “Surgical Oncology: A Practical and Comprehensive Approach” published by Springer in 2014. He is currently editing a textbook, Hepato-Pancreato-Biliary and Transplant Surgery: Practical Management of Dilemmas. Dr. Chu has won several awards including the ASCO Leadership Development Program, ACS Japan Traveling Award, the AHPBA Traveling Award, Ellis-Island Medals of Honor, the ACS Scholarship to the Brandeis Leadership Program in Health Policy and Management, and the ASCO Humanitarian Award.

Don’t Forget to RSVP: Lunch Symposium at SBI/ACR Breast Imaging Annual Meeting


Come learn about SCOUT® Radar Localization, a wire-free, zero-radiation solution for breast tumor localization. 
Dr. Nina Vincoff
Chief of Breast Imaging, Northwell Health, NY

Thursday, April 6, 2017
12:30 pm – 1:30 pm
 Westin Bonaventure Hotel & Suites
 Beverly Room, 2nd Floor

Click here to RSVP today!


Visit Cianna Medical during the convention at booth

This e-newsletter is brought to you by Cianna  Medical, Inc., a women’s health company dedicated to the innovative treatment of early-stage breast cancer. As the only company dedicated exclusively to breast conservation therapy, Cianna’s commitment is to improve care and reduce the burden breast cancer treatment places on nearly 300,000 women and their loved ones each year.